glp 1 agonist diabetes The role of GLP1 receptor agonists in adult-onset type mellitus The Unstoppable Rise of GLP-1

Overall, only phentermine and its derivatives as well as orlistat were available and used for weight management

However, a more recent RCT of 255 adults with nicotine dependence did not show any effect of adjunctive dulaglutide compared with standard of care (that is, behavioral counseling with varenicline) on cigarette abstinence over 12 weeks of treatment 117

From 2016 to 2020, the compound annual growth rate of long-acting GLP-1 agonists was as high as 50.1%, much higher than the 5.6% for short-acting GLP-1 agonists

The FLOW trial demonstrated meaningful reductions in kidney disease progression with semaglutide. The SELECT trial showed a 20% reduction in major adverse cardiovascular events in patients with obesity and established cardiovascular disease. These are not trivial findings

Such differences in compliance between GLP-1RA preparations are mainly due to the differences between injection devices [172]

In contrast to RCTs, retrospective observational studies offer the benefit of capturing extensive patient data in real-world settings